ConvergeHEALTH™ CGT Vantage
Orchestrating cell and gene therapies to better manage patient treatment journeys
A configurable solution that simplifies the orchestration of cell and gene therapies with clear visibility into Chain of Identity (COI) and Chain of Custody (COC) across industry stakeholders.
Why ConvergeHEALTH™ CGT Vantage?
Transform the management of cell and gene therapy patient journeys
Cell and gene therapy (CGT) has emerged as one of the fastest growing industries within Life Sciences. With the CGT supply chain being more complex than traditional pharma—requiring more stakeholders and touchpoints—organizations can simplify and manage this end-to-end capability by asking:
- How do we reduce time spent on user training and processes?
- How do we improve process transparency and collaboration between Contract Development and Manufacturing Organizations (CDMOs) and manufacturers?
- How can organizations cut back on costs?
ConvergeHEALTH™ CGT Vantage is a cell orchestration solution designed to optimize coordination within the complex cell and gene therapy ecosystem, enabling effective management of end-to-end patient treatment journeys.
${subhead-2}
${paragraph-2}
ConvergePROSPERITY™ BankingSuite
Developed specifically for banks with up to $100 billion in assets, the ConvergePROSPERITY BankingSuite helps your business rapidly design, plan, provision, and deploy personalized products and services ahead of customer expectations, deliver data and new insights to customers to help improve money management, and scale to increase revenue and grow market share.
The features
${subheader-text}
01
Standardized, configurable portal
From subject referral to enrollment and order management, the standardized user interface serves as a foundation for all CGT business process workflows while being configurable by the manufacturer at a therapy level.
02
COI & COC management
A standardized process provides generation of COI, barcoding, and labels, including full tracking of COC with all stakeholders and easy COC report generation.
03
Flexible order milestones
Provides flexible workflows for different types of variations in the patient journey. Manufacturers can then set up milestones as individual touchpoints when managing the patient journey.
04
Secure, scalable, cloud based
Hosted on AWS Cloud, this Software-as-a-Service solution is fully managed and operated by Deloitte, with multi-tenant capabilities that are GxP- and HIPAA- compliant.
05
Standardized integrations
Data exchanges to and from manufacturers and other ecosystem partners are handled using standard API designs and batch integrations.
06
Modularized
As a modularized solution, our flexible model enables manufacturers to subscribe to specific modules that best support their business processes.
Solution benefits
Health care providers
Provides access to a single, standardized portal to schedule patient cell and gene treatments regardless of therapy or manufacturer.
Manufacturers and CDMOs
Allows manufacturers to launch multiple therapies quickly, ensure operational transparency, and reduce time to market while providing complete tracking of COI and COC.
Ecosystem partners
Provides standardized APIs for integration into external systems to streamline the data exchange and provide operational transparency across the patient treatment journey.
${item-4-title}
${item-4-description}
${item-5-title}
${item-5-description}
${item-6-title}
${item-6-description}
${item-7-title}
${item-7-description}
${item-8-title}
${item-8-description}
Insights to guide your journey
